ATE213643T1 - Ciclosporin formulierung - Google Patents

Ciclosporin formulierung

Info

Publication number
ATE213643T1
ATE213643T1 AT97934627T AT97934627T ATE213643T1 AT E213643 T1 ATE213643 T1 AT E213643T1 AT 97934627 T AT97934627 T AT 97934627T AT 97934627 T AT97934627 T AT 97934627T AT E213643 T1 ATE213643 T1 AT E213643T1
Authority
AT
Austria
Prior art keywords
pct
ciclosporine
formulation
sec
date
Prior art date
Application number
AT97934627T
Other languages
English (en)
Inventor
Milan Stuchlik
Tomas Andrysek
Alexander Jegorov
Ales Husek
Vladimir Matha
Josef Stuchlik
Kvetoslava Benesova
Original Assignee
Ivax Cr A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Cr A S filed Critical Ivax Cr A S
Application granted granted Critical
Publication of ATE213643T1 publication Critical patent/ATE213643T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT97934627T 1996-08-01 1997-07-31 Ciclosporin formulierung ATE213643T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ19962289A CZ288739B6 (cs) 1996-08-01 1996-08-01 Cyklosporin obsahující léčivé přípravky
PCT/GB1997/002079 WO1998005309A1 (en) 1996-08-01 1997-07-31 Cyclosporin formulation

Publications (1)

Publication Number Publication Date
ATE213643T1 true ATE213643T1 (de) 2002-03-15

Family

ID=5464691

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97934627T ATE213643T1 (de) 1996-08-01 1997-07-31 Ciclosporin formulierung

Country Status (11)

Country Link
US (2) US6106860A (de)
EP (1) EP0917460B1 (de)
KR (1) KR100495417B1 (de)
AT (1) ATE213643T1 (de)
AU (1) AU3777197A (de)
CZ (1) CZ288739B6 (de)
DE (1) DE69710732T2 (de)
DK (1) DK0917460T3 (de)
ES (1) ES2171976T3 (de)
PT (1) PT917460E (de)
WO (1) WO1998005309A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
SE511313C2 (sv) * 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
GB9811854D0 (en) * 1998-06-02 1998-07-29 Ciba Geigy Ag Organic compounds
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
AU2002333098B2 (en) * 2001-10-19 2006-03-16 Isotechnika Pharma Inc. Novel cyclosporin analog microemulsion preconcentrates
GB2391473B (en) * 2002-08-02 2004-07-07 Satishchandra Punambhai Patel Pharmaceutical compositions
WO2004050688A1 (en) 2002-12-02 2004-06-17 Xenome Ltd NOVEL χ-CONOTOXIN PEPTIDES (-II)
ATE547424T1 (de) 2002-12-02 2012-03-15 Xenome Ltd Chi-conotoxinpeptide mit einer n-terminalen pyroglutaminsäure
KR100884189B1 (ko) * 2007-06-20 2009-02-18 심종원 치아세정수단의 탈부착이 가능한 샤워기

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky

Also Published As

Publication number Publication date
US6312721B1 (en) 2001-11-06
CZ228996A3 (cs) 1998-02-18
EP0917460B1 (de) 2002-02-27
WO1998005309A1 (en) 1998-02-12
AU3777197A (en) 1998-02-25
US6106860A (en) 2000-08-22
KR20000029746A (ko) 2000-05-25
ES2171976T3 (es) 2002-09-16
DE69710732D1 (de) 2002-04-04
CZ288739B6 (cs) 2001-08-15
DE69710732T2 (de) 2002-10-17
KR100495417B1 (ko) 2005-06-14
PT917460E (pt) 2002-07-31
DK0917460T3 (da) 2002-03-25
EP0917460A1 (de) 1999-05-26

Similar Documents

Publication Publication Date Title
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
HK1036931A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients.
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
TNSN00010A1 (fr) DIPHENYLUREE A SUBSTITUTION ω CARBOXYARYLE SERVANT D'INHIBUTEURS DE RAF KINASE.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
EA200100519A1 (ru) Композиции на основе тонкоизмельченного эплеренона
DE60021179D1 (de) Hautpflegemitteln enthaltend eine kombination von aktive wirkstoffen
PL347671A1 (en) Compounds and compositions for delivering active agents
MA26458A1 (fr) Nouveaux derives cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent.
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
IL140710A0 (en) Pulmonary delivery of active agents
GEP20002211B (en) Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
EP0828481A4 (de) Orale dosis zur intestinalen verabreichung sowie verfahren zu deren verwendung
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
PL316942A1 (en) Novel pharmaceutic compositions based on taxoides
DE69710732D1 (de) Ciclosporin formulierung
SE9801495D0 (sv) Protein formulationa
ATE179164T1 (de) Hiv-proteaseinhibitoren
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
EP0820770A3 (de) Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und ein Antioxidans enthält
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee